This report aims to provide detailed insights
into the global newborn
screening market. It provides valuable information on
the type, procedure, application, and region in the market. Furthermore, the
information for these segments, by region, is also presented in this report.
Leading players in the market are profiled to study their product offerings and
understand the strategies undertaken by them to be competitive in this market.
Revenue Growth Analysis:
The global newborn screening market size is projected to reach USD 1.3
billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141676244
Major Market Growth Drivers:
The Growth in this market is driven mainly by the growing awareness
regarding early diagnosis of diseases in newborn, rising newborn screen rate,
favorable government policies to conduct newborn screening.
The
consumables segment accounted for the largest share of the newborn screening
instruments market in 2019.
Based on the product, the newborn screening industry is segmented
into consumables and instruments. The consumables further segmented into Assay
kits & reagents and other consumables such as newborn screening cards and
columns. In 2019, consumables accounted for the largest share of the newborn
screening instruments market. The large share of this market segment is mainly
due to the constant requirement for consumables in newborn screening. The
increasing newborn screening rate across the globe also fuels the demand for
consumables.
The dry blood spot tests segment
accounted for the largest share of the newborn screening market in 2019.
The newborn screening industry, by test, is segmented into dry blood spot
tests, hearing screening tests, and critical congenital heart defect (CCHD)
screening tests. In 2019, the dry blood spot tests segment accounted for the
largest share of the newborn screening instruments market due to the wide
acceptance of dry blood spot tests for screening disorders. Most metabolic,
hormonal, and genetic disorders are diagnosed using dry blood spot tests.
Regional Growth Analysis:
North America accounted for the largest
share of the newborn screening market in 2019.
North America accounted for the largest share of the market in 2019. The
large share of this segment can primarily be attributed to the rising incidence
of newborn diseases, the availability of reimbursement for newborn screening test,
and the strong presence of industry players in the region.
The Asia Pacific is expected to
register the highest CAGR during the forecast period. Growth in this region is
driven by the large newborn pool, increasing screening rate, and rising
awareness regarding early diagnosis.
Key Market Players:
Some of the major players in the newborn screening market include Some of the
leading players in the market are PerkinElmer (US), Demant A/S (Denmark), Natus
Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), and
Medtronic (Ireland). Others include Chromsystems Instruments & Chemicals
GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Parseq Lab
(Russia), and Recipe Chemicals+Instruments (Germany).
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=141676244
India, China, and Brazil provide
significant opportunities to players in this market due to their high birth
rates and increasing disposable income. According to the UN Children’s Fund,
India records 25 million births every year, or nearly one-fifth of the global
annual childbirths. The high birth rate and the availability of newborn
screening in public hospitals indicates a strong demand for market products and
consumables.
